Resources Contact Us Home
Polynucleotides encoding myostatin binding agents

Image Number 6 for United States Patent #7803923.

The present invention provides binding agents comprising peptides capable of binding myostatin and inhibiting its activity. In one embodiment the binding agent comprises at least one myostatin-binding peptide attached directly or indirectly to at least one vehicle such as a polymer or an Fc domain. The binding agents of the present invention produced increased lean muscle mass when administered to animals and decreased fat to muscle ratios. Therapeutic compositions containing the binding agents of the present invention are useful for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity.

  Recently Added Patents
Bid optimization in search engine marketing
Fuel cell system, and electric vehicle equipped with the fuel cell system
Denial of service (DoS) attack prevention through random access channel resource reallocation
Philanthropy management apparatus, system, and methods of use and doing business
Stable file system
Base station synchronization for a single frequency network
Preparation of isomerically pure substituted cyclohexanols
  Randomly Featured Patents
Bottle top dispenser for handling liquids
Process for accelerated capture of carbon dioxide
Audible alarm with laminated magnetic core
Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
Amide penetration enhancers for transdermal delivery of systemic agents
Edge bead control method and apparatus
Non-aqueous electrolyte secondary cell with a lithium cobalt oxide positive electrode
Rock crusher attachment
Adirondack chair
Methods for detecting bacteriophage MS2